- Home
- CLDX vs CSTM Comparison
CLDX vs CSTM Comparison
Compare CLDX & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- CSTM
- Stock Information
- Founded
- CLDX N/A
- CSTM 2010
- Country
- CLDX United States
- CSTM France
- Employees
- CLDX N/A
- CSTM N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CSTM Metal Fabrications
- Sector
- CLDX Health Care
- CSTM Industrials
- Exchange
- CLDX Nasdaq
- CSTM Nasdaq
- Market Cap
- CLDX 1.3B
- CSTM 1.4B
- IPO Year
- CLDX 2008
- CSTM 2013
- Fundamental
- Price
- CLDX $16.85
- CSTM $10.14
- Analyst Decision
- CLDX Buy
- CSTM Buy
- Analyst Count
- CLDX 8
- CSTM 4
- Target Price
- CLDX $54.29
- CSTM $19.50
- AVG Volume (30 Days)
- CLDX 767.1K
- CSTM 1.4M
- Earning Date
- CLDX 05-05-2025
- CSTM 04-23-2025
- Dividend Yield
- CLDX N/A
- CSTM N/A
- EPS Growth
- CLDX N/A
- CSTM N/A
- EPS
- CLDX N/A
- CSTM 0.38
- Revenue
- CLDX $7,020,000.00
- CSTM $7,335,000,000.00
- Revenue This Year
- CLDX N/A
- CSTM $10.44
- Revenue Next Year
- CLDX $27.01
- CSTM $8.88
- P/E Ratio
- CLDX N/A
- CSTM $26.55
- Revenue Growth
- CLDX 1.99
- CSTM N/A
- 52 Week Low
- CLDX $16.75
- CSTM $9.04
- 52 Week High
- CLDX $47.00
- CSTM $23.20
- Technical
- Relative Strength Index (RSI)
- CLDX 29.79
- CSTM 37.21
- Support Level
- CLDX $19.48
- CSTM $9.76
- Resistance Level
- CLDX $20.38
- CSTM $11.76
- Average True Range (ATR)
- CLDX 1.03
- CSTM 0.43
- MACD
- CLDX -0.17
- CSTM -0.24
- Stochastic Oscillator
- CLDX 2.19
- CSTM 14.39
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About CSTM Constellium SE (France)
Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: i) Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium products in European and North American facilities. ii) Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities. iii) The Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.